Real World Study of Classic Infectious Disease

Summary

This study aimed to collect and analyze clinical specimens of patients with classic infectious diseases in the real world. To investigate the epidemiological distribution of classic infectious diseases (brucellosis, epidemic hemorrhagic fever, kala-azar) and treatment options suitable for China.

Conditions

• Brucelloses
• Epidemic Hemorrhagic Fever
• Kala-Azar

Interventions

DRUG

Antibiotics

Local doctors prescribe available antibiotics to the patients according to the guideline and patients' condition

Sponsors & Collaborators

• First Affiliated Hospital of Xinjiang Medical University

  collaborator OTHER

• First Affiliated Hospital of Harbin Medical University

  collaborator OTHER

• The ninth Hospital of NanChang city

  collaborator UNKNOWN

• Luoyang Central Hospital

  collaborator OTHER

• Second Affiliated Hospital of Nanchang University

  collaborator OTHER

• The Fifth Affiliated Hospital Xinjiang Medical University

  collaborator UNKNOWN

• LanZhou University

  collaborator OTHER

• Huzhou Central Hospital

  collaborator OTHER

• First Affiliated Hospital of Fujian Medical University

  collaborator OTHER

• Fuzhou Municipal Infectious Diseases Hospital

  collaborator UNKNOWN

• Henan Provincial People's Hospital

  collaborator OTHER

• The First Affiliated Hospital of Lanzhou Medical University

  collaborator UNKNOWN

• Linyi People's Hospital

  collaborator OTHER

• Nantong University

  collaborator OTHER

• Nanyang Central Hospital

  collaborator OTHER

• Qilu Hospital of Shandong University

  collaborator OTHER

• Qianfoshan Hospital

  collaborator OTHER

• Infectious Hospital of Jining City

  collaborator UNKNOWN

• The Affiliated Hospital of Jining Medical University and Zaozhuang City

  collaborator UNKNOWN

• The First Affiliated Hospital of Shanxi Medical University

  collaborator OTHER

• First Affiliated Hospital Xi'an Jiaotong University

  collaborator OTHER

• People's Hospital of Xinjiang Uygur Autonomous Region

  collaborator OTHER

• Yuncheng Central Hospital

  collaborator OTHER

• Zibo Central Hospital

  collaborator OTHER_GOV

• The Second Affiliated Hospital of Henan Medical University

  collaborator UNKNOWN

• West Hospital of the First Affiliated Hospital of Guangxi University

  collaborator UNKNOWN

• The First Hospital of Jilin University

  collaborator OTHER

• The Affiliated Hospital of Xuzhou Medical University

  collaborator OTHER

• The First Affiliated Hospital with Nanjing Medical University

  collaborator OTHER

• The First Affiliated Hospital of Anhui Medical University

  collaborator OTHER

• The Second Hospital of Shandong University

  collaborator OTHER

• The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

  collaborator OTHER

• Huashan Hospital

  lead OTHER

Eligibility

Min Age

18 Years

Max Age

75 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2020-05-13

Primary Completion

2024-06-01

Completion

2029-06-01

FDA Drug

Yes

Countries

• China

Study Locations